Abstract:Breast cancer is the most frequently diagnosed cancer among women, and the circulating tumor cell (CTC)-meditated distant metastasis is the leading cause of death. Thus, the detection of CTCs is of great importance for the early diagnosis of breast cancer and the prevention of metastasis. In this study, using human breast carcinoma BT474 cells as the model CTCs, a powerful assay platform is demonstrated by fluorescence spectrometry for the highly sensitive CTC detection by combining the dual-recognizing elements receptor-binding antibody and aptamer-mediated separation with double rolling circle amplification reactions (d-RCA, including RCA1 and RCA2). The aptamer-inserted RCA1 product (RCA1-p) exhibits the considerably improved affinity towards target cells originating from the multivalent binding effect. The immunomagnetic separation removes nontarget cells coexisting in complex biological milieu, while the centrifugal separation of cells/DNAs mixture eliminates the excess probes, thereby circumventing the unwanted interferences. The fluorescence spectrometric results show that a 34-fold enhanced fluorescence signal is achieved upon BT474 cells, and the target cells can be quantitatively detected down to 9 cells/200 μL with the linear range of five orders of magnitude, indicating a significantly enhanced detection performance. Even if BT474 cells are spiked in the fresh whole blood, no obvious fluctuation in the fluorescence signal is detected, demonstrating that the newly developed d-RCA assay system is suitable for screening CTCs in complex environments and is expected to be a promising tool for estimating distant metastasis and predicting the recurrence of tumors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.0c01082?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.0c01082</a>.Materials and reagents, comparison of detection capability between aptamer-mediated d-RCA and previous systems, nPAGE analysis to evaluate the RCA2-p productivity, optimization of experimental conditions, laser confocal microscope images, flow cytometry analysis to evaluate the signal amplification of the d-RCA system, specific recognition of the d-RCA system, and flow analysis based on a simplified detection scheme (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.0c01082/suppl_file/se0c01082_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

DNA-mediated reversible capture and release of circulating tumor cells with a multivalent dual-specific aptamer coating network.

The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.

Capture And Selective Release Of Multiple Types Of Circulating Tumor Cells Using Smart Dnazyme Probes

Designer tetrahedral DNA framework-based microfluidic technology for multivalent capture and release of circulating tumor cells

Accurate Isolation of Circulating Tumor Cells via a Heterovalent DNA Framework Recognition Element-Functionalized Microfluidic Chip

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells

DNA Hydrogel with Aptamer-Toehold-Based Recognition, Cloaking, and Decloaking of Circulating Tumor Cells for Live Cell Analysis

In situ signal amplification improves the capture efficiency of circulating tumor cells with low expression of EpCAM

Bioinspired DNA Nanointerface with Anisotropic Aptamers for Accurate Capture of Circulating Tumor Cells

Fabrication of a Polyvalent Aptamer Network on an Electrode Surface for Capture and Analysis of Circulating Tumor Cells

A Detachable Magnetic Nanodevice for the Efficient Capture and Subtype Identification of Circulating Tumor Cells

Combination of Immunomagnetic Separation with Aptamer-Mediated Double Rolling Circle Amplification for Highly Sensitive Circulating Tumor Cell Detection

Functionalized tetrahedral DNA frameworks for the capture of circulating tumor cells

DNA Framework-Programmed Cell Capture Via Topology-Engineered Receptor-Ligand Interactions.

Functional, UV-curable Coating for the Capture of Circulating Tumor Cells

Highly Efficient Capture and Electrochemical Release of Circulating Tumor Cells by Using Aptamers Modified Gold Nanowire Arrays.

Capture And "Self-Release" Of Circulating Tumor Cells Using Metal-Organic Framework Materials

A Microwell‐Assisted Multiaptamer Immunomagnetic Platform for Capture and Genetic Analysis of Circulating Tumor Cells

Beyond enumeration: Phenotype independent “labeling-capture-release” process enabling precise detection of circulating tumour cells and downstream applications

Direct Analysis of Rare Circulating Tumor Cells in Whole Blood Based on Their Controlled Capture and Release on Electrode Surface.